Carlsmed, a Carlsbad-based medical technology company specializing in personalized spine surgery solutions, has officially launched its initial public offering. The company plans to offer 6.7 million shares of common stock at a price range of $14 to $16 per share.

Carlsmed, a Carlsbad-based medical device company specializing in personalized spine fusion surgery, has filed to raise up to $100 million in an IPO. It markets its AI-enabled aprevo Technology Platform, including custom implants and single-use tools for lumbar procedures. With $32 million in revenue, Carlsmed aims to become the standard of care in spine fusion. It plans to trade on the Nasdaq under the symbol CARL. BofA Securities, Goldman Sachs, and Piper Sandler are leading the offering. Pricing terms have not been disclosed.

In the article “Industry experts share their outlook on the future of AMRs” from The Robot Report, industry leaders discuss the evolving landscape of Autonomous Mobile Robots (AMRs).

Cove Fund is proud to announce that our portfolio company, BLNG, has been featured in The New York Times for its groundbreaking work in revolutionizing the jewelry industry through artificial intelligence. The article, titled “Jewelry, Bling and Artificial Intelligence,” highlights how BLNG is transforming jewelry design and marketing by integrating advanced AI technologies.

BLNG AI, a Southern California generative AI platform transforming luxury jewelry by turning sketches into photorealistic designs and animated renderings, has secured $3 million in seed funding. The investment round was led by Speedinvest, with participation from Cove Fund, eSeed, and Focal.

The leading occupancy intelligence platform for the built environment, has secured a $6 million Series A investment led by Lewis & Clark Ventures with continued support from Shadow Ventures, Okapi Ventures, Cove Fund, and Hamilton Ventures.

The Indoor Football League (IFL), the premier indoor football league based in Sioux Falls, South Dakota, is thrilled to announce a groundbreaking partnership with Visaic, an AI-enabled fan engagement platform for sports and entertainment to unveil the newly designed IFL Network.

San Diego-based XILO, an InsurTech company providing quoting software for independent insurance agencies, has raised $7.2m in its latest Series A funding round.

Carlsmed, Inc., a MedTech company pioneering AI-enabled personalized spine surgery, today announced FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This milestone underscores Carlsmed’s commitment to advancing patient-specific spine surgery solutions that enhance outcomes and surgical precision.